SCM
SPRY icon

Sio Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Sio Capital Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-217,864
Closed -$1.85M – 56
2024
Q2 		$1.85M Sell
217,864
-318,299
-59% -$2.82M 0.7% 31
2024
Q1 		$5.48M Sell
536,163
-569,748
-52% -$4.25M 1.91% 19
2023
Q4 		$6.06M Hold
1,105,911
– – 1.56% 17
2023
Q3 		$4.18M Buy
1,105,911
+563,335
+104% +$3.7M 1.29% 22
2023
Q2 		$3.64M Buy
+542,576
New +$3.62M 1.29% 22

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return